Coraxel USA and Amanat Acquisition Corp announce a definitive business combination agreement to create an obesity-focused biopharmaceutical company.
🇺🇸 USA · Map
Coraxel USA and Amanat Acquisition Corp announce a definitive business combination agreement to create an obesity-focused biopharmaceutical company.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in